Media coverage
17
Media coverage
Title Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Patients with Moderate-To-Severe Pruritus Media name/outlet Morningstar.com Country/Territory United States Date 28/03/22 URL https://www.morningstar.com/news/globe-newswire/8510428/cara-therapeutics-announces-oral-korsuva-difelikefalin-improves-itch-and-inflammatory-biomarkers-in-atopic-dermatitis-patients-with-moderate-to-severe-pruritus Persons Emma Guttman Title Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Patients with Moderate-To-Severe Pruritus Media name/outlet Street Insider Country/Territory United States Date 28/03/22 URL https://www.streetinsider.com/Press+Releases/Cara+Therapeutics+Announces+Oral+KORSUVA%E2%84%A2+%28difelikefalin%29+Improves+Itch+and+Inflammatory+Biomarkers+in+Atopic+Dermatitis+Patients+with+Moderate-To-Severe+Pruritus/19829173.html Persons Emma Guttman Title Cara Therapeutics (CARA) Announces Oral KORSUVA Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Patients with Moderate-To-Severe Pruritus Media name/outlet Street Insider Country/Territory United States Date 28/03/22 URL https://www.streetinsider.com/Corporate+News/Cara+Therapeutics+%28CARA%29+Announces+Oral+KORSUVA+Improves+Itch+and+Inflammatory+Biomarkers+in+Atopic+Dermatitis+Patients+with+Moderate-To-Severe+Pruritus/19829298.html Persons Emma Guttman Title Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Patients with Moderate-To-Severe Pruritus Media name/outlet TMC Net Country/Territory United States Date 28/03/22 URL https://www.tmcnet.com/usubmit/-cara-therapeutics-announces-oral-korsuvatrade-difelikefal-improves-itch-/2022/03/28/9571262.htm Persons Emma Guttman Title Cara Therapeutics Announces Oral KORSUVA (difelikefalin) Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Patients with Moderate-To-Severe Pruritus Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 28/03/22 Persons Emma Guttman Title Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Patients with Moderate-To-Severe Pruritus Media name/outlet ADVFN UK Country/Territory United Kingdom Date 28/03/22 URL https://uk.advfn.com/stock-market/NASDAQ/CARA/share-news/Cara-Therapeutics-Announces-Oral-KORSUVA-difelike/87667937 Persons Emma Guttman Title Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Patients with Moderate-To-Severe Pruritus Media name/outlet Yahoo! Canada Country/Territory Canada Date 28/03/22 URL https://ca.sports.yahoo.com/news/cara-therapeutics-announces-oral-korsuva-110000488.html Persons Emma Guttman Title Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Patients with Moderate-To-Severe Pruritus Media name/outlet Yahoo! Finance Country/Territory United States Date 28/03/22 URL https://finance.yahoo.com/news/cara-therapeutics-announces-oral-korsuva-110000488.html Persons Emma Guttman Title Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Patients with Moderate-To-Severe Pruritus Media name/outlet MarketScreener.com Country/Territory United States Date 28/03/22 URL https://www.marketscreener.com/quote/stock/CARA-THERAPEUTICS-INC-15672075/news/Cara-Therapeutics-Announces-Oral-KORSUVA-trade-difelikefalin-Improves-Itch-and-Inflammatory-Bioma-39885527/ Persons Emma Guttman Title Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Patients with Moderate-To-Severe Pruritus Media name/outlet Customer Zone 360.com Country/Territory United States Date 28/03/22 URL www.customerzone360.com/news/2022/03/28/9571262.htm Persons Emma Guttman Title Oral KORSUVA(TM) (difelikefalin) Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Patients with Moderate To Severe Pruritus Media name/outlet Market News Publishing Country/Territory United States Date 28/03/22 Persons Emma Guttman Title Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Patients with Moderate-To-Severe Pruritus Media name/outlet GlobeNewswire Country/Territory United States Date 28/03/22 URL https://www.globenewswire.com/news-release/2022/03/28/2410827/29236/en/Cara-Therapeutics-Announces-Oral-KORSUVA-difelikefalin-Improves-Itch-and-Inflammatory-Biomarkers-in-Atopic-Dermatitis-Patients-with-Moderate-To-Severe-Pruritus.html Persons Emma Guttman Title Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Inflammatory ... Media name/outlet KULR 8 Country/Territory United States Date 28/03/22 URL https://www.kulr8.com/news/money/cara-therapeutics-announces-oral-korsuva-difelikefalin-improves-itch-and-inflammatory/article_ae1a55e3-5c8f-5cb5-9fc6-8bf8431d255f.html Persons Emma Guttman Title Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Inflammatory Media name/outlet Bluefield Daily Telegraph Country/Territory United States Date 28/03/22 URL https://www.bdtonline.com/news/nation_world/cara-therapeutics-announces-oral-korsuva-difelikefalin-improves-itch-and-inflammatory/article_c9ab211e-ee04-503a-8284-e401b909a1c3.html Persons Emma Guttman Title Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Patients with Moderate-To-Severe Pruritus Media name/outlet BizWire Express Country/Territory India Date 28/03/22 URL www.bizwireexpress.com/showstoryGNW.php?storyid=363869 Persons Emma Guttman Title Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Patients with Moderate-To-Severe Pruritus; Data presented in late-breaking session at the 2022 American Academy of Dermatology (AAD) A Media name/outlet PrimeNewswire (Top News) Country/Territory United States Date 28/03/22 Persons Emma Guttman Title Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Patients with Moderate-To-Severe Pruritus Media name/outlet Forex TV Country/Territory United States Date 28/03/22 URL https://forextv.com/top-news/cara-therapeutics-announces-oral-korsuva-difelikefalin-improves-itch-and-inflammatory-biomarkers-in-atopic-dermatitis-patients-with-moderate-to-severe-pruritus/ Persons Emma Guttman